Skip to main content
Clinical Trials/IRCT20160410027311N6
IRCT20160410027311N6
Recruiting
未知

The effect of selenium and vit E supplementation on anti-mullerian hormone (AMH) index and antral follicle count in infertile women with occult premature ovarian insufficiency: A randomized contorolled clinical trial

Tabriz University of Medical Sciences0 sites70 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Tabriz University of Medical Sciences
Enrollment
70
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Accepting informed written consent
  • Women aged 20 to 40 years old
  • Menstrual cycle
  • Having two ovaries
  • There is no evidence of endocrine disorders (diabetes, thyroid disorders, Addison's disease, etc.) by asking the patient and checking out the results of previous patient tests.
  • Occult POI (hormone AMH \<1 ng / ml, reduced ovarian reserve, less than 5 anthral follicles, reduced ovarian volume to less than 2\.5 cubic centimeters, or all three cases)
  • With BMI \<30, the weight and height in this study will be measured by the researcher and the BMI will be calculated according to the formula below. BMI \= (WEIGHT (kg)) / (LENGTH (m ^ 2\))

Exclusion Criteria

  • Drug Addiction and Smoking
  • The tendency to use donated eggs
  • Having evidence of OVERT POI (FSH\> 15 or amenorrhea for more than 3 months)
  • Supplementation of selenium and vitamin E three months before the onset of intervention
  • Having a history of radiotherapy and chemotherapy
  • The use of anticoagulants (co\-administration of vitamin E with these drugs increases the risk of bleeding)

Outcomes

Primary Outcomes

Not specified

Similar Trials